The Danish firm blamed the move to slash its guidance on intense competition from rivals and copycat drugs in the US.

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...

Weight loss injections could be key to controlling a chronic condition in thousands of Brits, new research suggests ...

India's weight-loss game is getting serious! The country's anti-obesity market is now worth ₹628 crore, and it's climbing ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

A new Mounjaro user has opened up on their experience taking the drug - including the one side effect they're struggling with ...

A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...

Weight loss jab users have panicked over going cold turkey after pharmacists warned of potential shortages in the UK due to ...

Weight loss injections like Ozempic, Wegovy, and Mounjaro have revolutionized the obesity fight, helping millions of Americans shed stubborn pounds, lower their blood sugar, and reduce their risk of ...

New research has revealed that people taking weight loss drugs like Wegovy and Mounjaro are increasingly more likely to ...